Irish nebulizer manufacturer Aerogen has received authorization from the Chinese State Food and Drug Administration (SFDA) to market its Aeroneb Pro and Aeroneb Go vibrating mesh nebulizers in China. The company expects to begin selling the products in the country by March 2012, with distributed handled by Gaelmed. Aerogen currently markets products in 65 countries.
CEO John Power commented “The rapidly growing Chinese market is receptive to international products of the highest standard, and plays a key role in Aerogen’s ambitious plans for growth. We are looking forward to being a part of that market, and bringing to Chinese patients for the first time the benefits enjoyed by users of our products across the globe.”
Read the Aerogen press release.
